In summary, to the best of our knowledge, this was the first study that explored by means of an extensive targeted NGS panel the muta- tional profile of HCV-associated B-cell LPDs, identifying recurrently mutated genes and pathways. Our results demonstrate also that a subset of HCV-related LPDs may harbor distinct molecular and immu- nogenetic features and bring out the potential correlation between specific BCR configurations, genetic lesions and regression of the lymphoproliferation after HCV eradication. A clinical trial with DAAs in indolent HCV-positive lymphomas is ongoing with ancillary biologi- cal studies and will provide further data in this setting (NCT02836925).

Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders

Bruno, Raffaele;Paulli, Marco;Arcaini, Luca
2021-01-01

Abstract

In summary, to the best of our knowledge, this was the first study that explored by means of an extensive targeted NGS panel the muta- tional profile of HCV-associated B-cell LPDs, identifying recurrently mutated genes and pathways. Our results demonstrate also that a subset of HCV-related LPDs may harbor distinct molecular and immu- nogenetic features and bring out the potential correlation between specific BCR configurations, genetic lesions and regression of the lymphoproliferation after HCV eradication. A clinical trial with DAAs in indolent HCV-positive lymphomas is ongoing with ancillary biologi- cal studies and will provide further data in this setting (NCT02836925).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1424254
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact